* T2 Biosystems Inc TTOO.OQ TTOO.O is expected to show a
fall
in quarterly revenue when it reports results on February 15 for
the period ending December 31 2023
* The Lexington Massachusetts-based company is expected to
report
a 56.2% decrease in revenue to $2.4 million from $5.48 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for T2 Biosystems Inc is for
a
loss of $2.22 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for T2
Biosystems Inc
is $8.68, above its last closing price of $6.49.
This summary was machine generated February 13 at 21:32 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)